Professional Documents
Culture Documents
CT and Mri Evaluation of Skull Bones and Soft Tissues in Six Cats With Presumed Acromegaly Versus 12 Unaffected Cats
CT and Mri Evaluation of Skull Bones and Soft Tissues in Six Cats With Presumed Acromegaly Versus 12 Unaffected Cats
CT and Mri Evaluation of Skull Bones and Soft Tissues in Six Cats With Presumed Acromegaly Versus 12 Unaffected Cats
Feline acromegaly is predominantly caused by an adenoma of the pituitary gland, resulting in excessive growth
hormone and insulin-like growth factor (IGF-1) secretion. In advanced cases, cats will display prominent facial
features and upper airway congestion secondary to bony and soft tissue proliferation. The purpose of this
study was to describe CT and MRI characteristics of soft tissues and skull bones in six cats with presumed
acromegaly and to compare findings with those observed in 12 unaffected cats. In the five acromegalic cats with
CT or MRI evidence of a pituitary tumor, frontal bone thickness was greater than age-matched controls with
and without a history of upper airway disease. These five cats also had evidence of soft tissue accumulation in
the nasal cavity, sinuses, and pharynx. One cat with insulin-resistant diabetes mellitus, elevated IGF-1, and
a normal pituitary size did not have evidence of frontal bone thickening or upper airway congestion. C 2012
Key words: CT, growth hormone, hyperostosis, insulin-like growth factor, MR, sinonasal disease.
1
2 FISCHETTI, GISSELMAN, AND PETERSON 2012
between 2006 and 2012, and for cats that also had CT∗
or MR† of the head. Cats were defined as acromegalic if
they had insulin-resistant diabetes mellitus (>6 U/dose)14
and elevated serum IGF-1 (normal = 5–70 nmol/l). Cats
that had skull CT scans performed for reasons other than
pituitary disease and had a history of chronic upper air-
way disease (stridor, congestion, or nasal discharge), cats
with suspected pituitary disease other than acromegaly, and
cats without history of pituitary or upper respiratory dis-
ease were included as controls. Controls were age matched
and chosen by randomized selection from our imaging and
medical record database, limiting our search by species, age,
modality, and diagnosis.
The following information was recorded from medical
records of acromegalic cats: age, sex, breed, history of nasal
discharge or stridor, physical exam evidence of facial defor-
mity and prognathia, duration of diabetes mellitus, and
IGF-1 value. FIG. 1. Example of frontal bone thickness measurements made from a
transverse CT image of a control cat without history of upper respiratory
Skull CT studies included the tip of the nose to mid-C2, disease (group B). Measurements were made at the level of the olfactory
with 3-mm-thick slices, standard and bone algorithm re- lobes, midway between the rostral and caudal-most extent of the frontal
constructions, and pre- versus postintravenous contrast.‡ sinus. The black line represents frontal bone thickening (FBT). The white
line represents the height from the dorsal margin of the frontal bone to the
Brain MR studies included transverse, pre- and postcon- ventral margin of the cranial vault (HFBCV).
trast§ T1-weighted images, and transverse and sagittal T2-
weighted images. Sagittal MR images included the nasal
cavity, but transverse images did not. All transverse CT
and MRI images were obtained perpendicular to the hard
palate.
From the bone algorithm transverse CT images win-
dowed for bone, measurements of FBT and PBT were made.
All measurements were made by a single author (A.J.F.)
blinded to group assignment. An average of three values
was obtained for each measurement. Frontal bone thick-
ness and height from the dorsal margin of the frontal bone
to the ventral margin of the cranial vault (HFBCV) were
measured at the level of the rostral olfactory bulbs (Fig.
1). Frontal bone thickness was made 0.2 cm from midline,
and HFBCV was made 0.4 cm from midline. Parietal bone
thickness and height from the dorsal margin of the parietal
bone to the ventral margin of the cranial vault (HPBCV) FIG. 2. Example of parietal bone thickness (PBT) measurements made
were measured at the level of the orbital fissure (Fig. 2). from a transverse CT image of a control cat without history of upper respira-
Parietal bone thickness was measured 0.2 cm from midline, tory disease (group B). Measurements were made at the rostral aspect of the
parietal bone, at the level of the oribital fissure entrance into the skull. The
and HPBCV was made 0.4 cm from midline. The maxi- black line represents PBT. The white line represents the height of the parietal
mum height of the pituitary gland was measured on the bone to the ventral margin of the cranial vault (HPBCV).
transverse postcontrast CT images (standard algorithm,
soft tissue window), acquired 30–40 s after bolus injection. Statistical Analyses
Subjective findings also recorded were soft tissue thicken-
ing in the nasal passages, frontal sinus, sphenoid sinus, and Cats were divided into three groups for statistical com-
oropharynx; and remodeling of the temporomandibular parisons. Categorical data were described in percentages.
joint and mandible. Statistical analyses were performed using commercially
available software.∗∗ Data are described as median ± in-
terquartile range (IQR). Normality of data was tested us-
∗ GE CTi single-detector CT, GE Healthcare, Milwaukee, WI.
† Philips
ing the Shapiro–Wilk test. One-way analysis of variance
Achieva, 1.5T MR, Andover, MA.
‡ Iohexol-240, Omnipaque, GE Healthcare, Wakesha, WI.
§ Magnevist, Bayer Healthcare Pharmaceuticals, Inc, Wayne, NJ. ∗∗ SigmaPlot
R
11 Systat Software, Inc, San Jose, CA 95110.
VOL. 00, NO. 0 BONE AND SOFT TISSUE PROLIFERATION IN FELINE ACROMEGALY 3
(Figs. 4 and 5). One of these cats (Fig. 5) also had physical In conclusion, cats with suspected acromegaly that un-
exam evidence of mandibular enlargement (Fig. 5). dergo CT or MR imaging of the head for pituitary tumors
One cat in group A (insulin-resistant diabetes mellitus may also show evidence of frontal bone thickening and soft
and elevated serum IGF-1) did not have evidence of bony or tissue proliferation of the upper airway, paranasal sinuses,
soft tissue proliferation. This cat also did not have imaging and ventral mandible. These findings may be present in af-
evidence of a pituitary tumor. Acromegaly in cats without fected cats with no clinical signs of facial enlargement or
imaging features of a pituitary mass has been previously upper respiratory disease and may provide further support
reported and determined to be secondary to pituitary hy- for a diagnosis of acromegaly.
perplasia on necropsy.2, 3 Additionally, elevations in serum
IGF-1 have been reported in well-regulated diabetic cats
ACKNOWLEDEMENTS
without acromegaly.3, 7 These scenarios make the definitive The authors would like to thank Dr. Philip R. Fox, DVM, MS,
diagnosis of acromegaly challenging. Having other pheno- DACVIM/ECVIM (Cardiology), DACVECC for his assistance with
typic changes can support the diagnosis. statistical testing and analysis.
REFERENCES
1. Peterson ME, Taylor RS, Greco DS, et al. Acromegaly in 14 cats. J 11. Meij BP, Auriemma E, Grinwis G, et al. Successful treatment of
Vet Intern Med 1990;4:192–201. acromegaly in a diabetic cat with transphenoidal hypophysectomy. J Feline
2. Elliott DA, Feldman EC, Koblik PD, et al. Prevalence of pituitary Med Surg 2010;12:406–10.
tumors among diabetic cats with insulin resistance. J Am Vet Med Assoc 12. Niessen S. Feline acromegaly–an essential differential diagnosis for
2000;216:1765–1768. the difficult diabetic. J Feline Med Surg 2009;12:15–23.
3. Niessen SJM, Petrie G, Gaudiano F, et al. Feline acromegaly: an 13. Posch B, Dobson J, Herrtage M. Magnetic resonance imaging findings
underdiagnosed endocrinopathy? J Vet Intern Med 2007;21:899–905. in 15 acromegalic cats. Vet Radiol Ultrasound 2011;52:422–27.
4. Gunn-Moore D. Acromegaly feline endocrinopathies: acromegaly. 14. Feldman EC, Nelson RW. Diabetes mellitus. In: Canine and feline
Vet Clin North Am Small Anim Pract 2005;35:181–187. endocrinology and reproduction, 2nd ed. Philadelphia, PA: W. B. Saunders,
5. Katznelson L. Alterations in body composition in acromegaly. Pitu- 1996; 376.
itary 2009;12:136–142. 15. Wallack ST, Wisner ER, Feldman EC. Mensuration of the pituitary
6. Feldman EC, Nelson RW. Acromegaly and hyperadrenocorticism in gland from magnetic resonance images in 17 cats. Vet Radiol Ultrasound
cats: A clinical perspective. J Feline Med Surg 2000;2:153–158. 2003;44:278–282.
7. Berg RI, Nelson RW, Feldman EC, et al. Serum insulin-like growth 16. She R, Szakacs J. Hyperostosis frontalis interna: case report and re-
factor-1 in cats with diabetes mellitus and acromegaly. J Vet Intern Med view of the literature. Ann Clin Lab Sci 2004;34:206–08.
2007;21:889–91. 17. Barmeir EP, Lipschitz S, Dubowitz, et al. Diagnosis of acromegaly on
8. Hermann BL, Mortsch F, Berg C, et al. Acromegaly: a cross-sectional cranial computed tomography. Isr J Med Sci 1982;18:830–34.
analysis of the oral and maxillofacial pathologies. Exp Clin Endocrinol Dia- 18. Zatonski T, Bolanowski M, Skrzypek A, et al. Evaluation of tem-
betes 2001;119:9–14. poral bone computed tomography and paranasal sinuses magnetic reso-
9. Ebner FH, Kurshner V, Kietz K, et al. Craniometric changes in nance images in acromegalic patients. Neuro Endocrinol Lett 2010;31:796–
patients with acromegaly from a surgical perspective. Neurosurg Focus 800.
2010;29:E3. 19. Iikubo M, Kobayashi A, Kojima I, et al. Excessive lateral dental arch
10. Skinner DW, Richards SH. Acromegaly—the mucosal changes within expansion in experimentally developed acromegaly-like rats. Arch Oral Biol
the nose and paranasal sinuses. J Laryngol Otol 1988;102:1107–10. 2008;53:924–27.